Searched for
CDMO SERVICES
Brokerages stay bullish on Laurus Labs as CDMO momentum and margins improveLaurus Labs' stock has surged 30% on robust FY26 results, fueled by a booming contract manufacturing business and improved product mix. The...26 Jun, 2026, 06.37 AM IST- Banking, capital goods and midcaps seen driving market's next rally: Ashish ChaturmohtaIndian equities are poised for fresh highs, driven by strong earnings and sector-specific momentum, particularly in financials and manufact...22 Jun, 2026, 11.48 AM IST
- The 30% smallcap tilt: How Abakkus Flexi Cap Fund is positioning for the next rallyAbakkus Mutual Fund is strategically allocating 30% to smallcaps within its Flexi Cap Fund, identifying mispriced opportunities despite str...17 Jun, 2026, 09.36 AM IST
- Sweet pills: How pharma stocks delivered bumper returns to Indian investors, defying 2026 whiplashIndian pharma stocks are outperforming the market, offering strong returns to investors. This resilience is driven by robust domestic deman...11 Jun, 2026, 10.31 AM IST
- Nifty Pharma, 4 others hit 52-week high since Iran war while Nifty fell 7%. Will the form continue?Despite a challenging market backdrop fueled by geopolitical tensions and foreign fund outflows, five Indian sectors—Pharma, Energy, Defenc...25 May, 2026, 10.31 AM IST
- Nifty stuck in a range but small and midcaps are where real money is being made: Ashish ChaturmohtaIndian stock markets may appear stagnant, but opportunities exist in small and midcap stocks. JM Financial's Ashish Chaturmohta highlights ...22 May, 2026, 01.38 PM IST
- Laurus Labs adds Rs 40,150 crore to investors' wealth in a year with 120% rally. Buy, hold or book profits?Laurus Labs has significantly boosted investor wealth, adding over Rs 40,000 crore in a year with a 120% stock rally. Driven by business im...19 May, 2026, 10.34 AM IST
- Geopolitical tensions keep markets nervous despite strong earnings: Dipan MehtaGeopolitical tensions, particularly the Iran crisis, are overshadowing strong corporate earnings, according to Dipan Mehta. While India Inc...13 May, 2026, 01.17 PM IST
- Earnings season is strong, but Q1 pain is coming: Dipan MehtaMarket expert Dipan Mehta finds India's current earnings season strong. He notes that future quarters will test corporate India due to pote...07 May, 2026, 11.05 AM IST
- Mayuresh Joshi's top picks: Chemicals the dark horse, underweight on ITIndian markets delivered strong earnings, but opportunities vary. Autos show stable demand with input cost risks. Chemicals are a potential...06 May, 2026, 02.07 PM IST
- Crude shock temporary; pharma and EMS are the real bets: Abhay AgarwalGeopolitical fears are driving crude oil prices higher, but Piper Serica's Abhay Agarwal believes this is a temporary, sentiment-driven spi...30 Apr, 2026, 09.36 AM IST
- Sun Pharma deal: Perception changer for Indian pharma sector? 10 pharma stocks with upside potential of up to 38%The Indian pharma sector made its initial global forays almost a quarter century ago. Companies sought out markets abroad, learnt to deal w...29 Apr, 2026, 02.22 PM IST
- Granules India shares in focus on acquiring Swiss firm for Rs 192 crGranules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market presence. The ...24 Feb, 2025, 08.27 AM IST
- Granules acquires Swiss firm for Rs 192 cr; forays into CDMO spaceGranules India has acquired Swiss CDMO firm Senn Chemicals AG for CHF 20 million, expanding into the peptide therapeutics segment. The acqu...21 Feb, 2025, 10.52 PM IST
- Suven, Cohance aim to double combined business revenue to Rs 6,000 cr by FY29Suven Pharmaceuticals and Cohance Lifesciences plan to merge and aim to double their revenue to Rs 6,000 crore by FY29 through organic and ...01 Nov, 2024, 03.01 PM IST
- Innova Captab share price jumps 20% after tepid listing. What should investors do?The lackluster debut performance fell way short of expectations, which highlights the potential risks associated with the highly competitiv...29 Dec, 2023, 02.45 PM IST
- Innova Captab shares list at just 2% premium over issue priceThe IPO of Innova Captab received tremendous response from investors with 55.26 times subscription at close. The issue received bids of 50,...29 Dec, 2023, 10.01 AM IST
Load More
